Nexus Surgical and Medicare (BSE 538874)₹24.45+10.18%Other Financial Services
In the Mar 2026 quarter (standalone), Nexus Surgical and Medicare reported sales of ₹2.04 Cr, up 38.8% from Mar 2025, and net profit of ₹0.23 Cr, up 187.5% year on year. For the year to Mar 2026, sales were ₹7.86 Cr and net profit ₹0.73 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.05 | 0.36 | 1.44 | 0.59 | 1.75 | 0.98 | 1.47 | 1.47 | 1.72 | 1.16 | 2.92 | 2.04 |
| Expenses | 1.02 | 0.29 | 1.39 | 0.51 | 1.65 | 0.70 | 1.34 | 1.36 | 1.54 | 0.93 | 2.70 | 1.74 |
| Operating Profit | 0.02 | 0.08 | 0.04 | 0.07 | 0.11 | 0.27 | 0.14 | 0.12 | 0.19 | 0.22 | 0.21 | 0.29 |
| OPM % | 2.8% | 24.3% | 3.5% | 13.4% | 6.9% | 28.3% | 10.2% | 7.4% | 11.6% | 19.7% | 7.5% | 14.7% |
| Other Income | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.03 | 0.10 | 0.05 | 0.07 | 0.11 | 0.27 | 0.14 | 0.11 | 0.19 | 0.22 | 0.22 | 0.31 |
| Tax % | 25.0% | 27.2% | 33.3% | 25.0% | 25.0% | 24.9% | 26.6% | 25.0% | 25.0% | 26.1% | 26.1% | 25.0% |
| Net Profit | 0.02 | 0.07 | 0.04 | 0.05 | 0.08 | 0.20 | 0.10 | 0.08 | 0.14 | 0.16 | 0.16 | 0.23 |
| EPS (Rs) | 0.04 | 0.14 | 0.08 | 0.10 | 0.15 | 0.37 | 0.19 | 0.15 | 0.26 | 0.30 | 0.30 | 0.43 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.32 | 0.29 | 0.97 | 2.13 | 1.72 | 3.73 | 2.39 | 1.54 | 3.46 | 5.71 | 7.86 | 7.84 |
| Expenses | 0.26 | 0.49 | 1.37 | 2.33 | 1.67 | 3.57 | 2.02 | 1.32 | 3.19 | 5.04 | 6.90 | 6.91 |
| Operating Profit | 0.07 | −0.19 | −0.37 | −0.17 | 0.08 | 0.15 | 0.36 | 0.21 | 0.26 | 0.68 | 0.95 | 0.91 |
| OPM % | 24.3% | −60.0% | −38.7% | −8.4% | 4.1% | 4.3% | 15.5% | 14.2% | 7.8% | 11.7% | 12.2% | 11.6% |
| Other Income | 0.00 | 0.00 | 0.05 | 0.07 | −5.34 | 0.00 | 0.01 | 0.00 | 0.02 | 0.00 | 0.02 | 0.01 |
| Interest | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.06 | −0.18 | −0.31 | −0.09 | −5.27 | 0.16 | 0.38 | 0.22 | 0.28 | 0.66 | 0.98 | 0.94 |
| Tax % | 28.5% | 0.0% | 3.1% | 0.0% | 0.4% | 5.9% | 25.7% | 26.1% | 27.5% | 25.3% | 25.2% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | −5.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.04 | −0.18 | −0.32 | −0.10 | −5.29 | 0.14 | 0.28 | 0.16 | 0.20 | 0.49 | 0.73 | 0.69 |
| EPS (Rs) | 0.08 | −0.34 | −0.59 | −0.19 | −9.65 | 0.26 | 0.52 | 0.30 | 0.37 | 0.90 | 1.34 | 1.29 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.50 | 5.48 | 5.49 | 5.48 | 5.48 | 5.48 | 5.48 | 5.47 | 5.48 | 5.47 | 5.48 | 5.47 |
| Reserves | 0.12 | 0.16 | 0.00 | −0.32 | −0.43 | −5.72 | −5.57 | −5.29 | −5.11 | −4.91 | −4.40 | −3.66 |
| Borrowings | 0.00 | 0.10 | 0.30 | 0.26 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.13 | 0.04 | 0.18 | 0.20 | 0.20 | 0.47 | 1.04 | 1.82 | 0.56 | 1.25 | 1.21 | 1.86 |
| Total Liabilities | 5.75 | 5.78 | 5.97 | 5.62 | 5.52 | 0.23 | 0.95 | 2.00 | 0.93 | 1.81 | 2.29 | 3.67 |
| Fixed Assets | 0.04 | 0.02 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.03 | 0.01 | 0.03 | 0.03 |
| CWIP | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.35 | 0.40 | 0.57 | 0.23 | 0.13 | 0.20 | 0.92 | 2.00 | 0.90 | 1.80 | 2.26 | 3.64 |
| Inventories | 0.00 | 0.04 | 0.12 | 0.05 | 0.00 | 0.00 | 0.00 | 0.42 | 0.08 | 0.41 | 0.44 | 0.38 |
| Trade receivables | 0.19 | 0.24 | 0.25 | 0.11 | 0.05 | 0.00 | 0.13 | 0.00 | 0.05 | 0.76 | 1.35 | 1.33 |
| Cash & equivalents | 0.02 | 0.08 | 0.11 | 0.00 | 0.03 | 0.01 | 0.21 | 0.10 | 0.64 | 0.22 | 0.32 | 0.49 |
| Total Assets | 5.75 | 5.78 | 5.97 | 5.62 | 5.52 | 0.23 | 0.95 | 2.00 | 0.93 | 1.81 | 2.29 | 3.67 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.02 | −0.02 | −0.16 | −0.06 | 0.01 | 0.23 | 0.19 | −0.10 | 0.54 | −0.40 | 0.09 | 0.16 |
| Cash from investing activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from financing activity | 0.00 | 0.10 | 0.21 | −0.05 | 0.02 | −0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net cash flow | 0.04 | 0.06 | 0.04 | −0.12 | 0.04 | −0.03 | 0.21 | −0.12 | 0.55 | −0.43 | 0.11 | 0.18 |
| Capex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.02 | 0.00 |
| Free cash flow | 0.02 | −0.02 | −0.16 | −0.06 | 0.01 | 0.23 | 0.19 | −0.10 | 0.53 | −0.40 | 0.08 | 0.16 |
| CFO / OP % | 23.0% | 12.0% | 94.0% | 18.0% | −11.0% | 343.0% | 125.0% | −30.0% | 250.0% | −152.0% | 15.0% | 18.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 152 | 253 | 291 | 36 | 6 | 0 | 11 | 0 | 8 | 78 | 85 | 60 |
| Inventory days | — | 156 | 138 | 15 | 0 | 0 | 0 | — | 57 | 243 | 84 | 55 |
| Days payable | — | 105 | 228 | 73 | — | — | — | — | 455 | 755 | 231 | 240 |
| Cash conversion cycle | 153 | 307 | 204 | −20 | 7 | 0 | 12 | 0 | −388 | −432 | −61 | −123 |
| Working capital days | 154 | 278 | −72 | −100 | −66 | −73 | −43 | −19 | −77 | 30 | 46 | 60 |
| ROCE % | 4.0% | 1.4% | −3.1% | −5.7% | −1.9% | 2.8% | — | 1,114.4% | 86.8% | 66.0% | 84.0% | 69.3% |
For the Mar 2026 quarter, Nexus Surgical and Medicare reported sales of ₹2.04 Cr, up 38.8% year on year and net profit of ₹0.23 Cr, up 187.5% year on year. The operating margin was 14.7%.
Nexus Surgical and Medicare's sales for the year to Mar 2026 were ₹7.86 Cr; over the last twelve months they were ₹7.84 Cr.
Net profit for the year to Mar 2026 was ₹0.73 Cr, and ₹0.69 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.29.
Nexus Surgical and Medicare reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.49 Cr.
Cash from operations was ₹0.16 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.16 Cr.